The condition called Rhinitis is a swelling inside the nose, which is caused by allergies, infections, or irritants like dust ...

Merve Ceylan is a dietitian and health writer with four years of experience writing for companies in the nutrition and health industry. Black seed oil (Nigella sativa), also called black cumin or ...

The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for ...

An announcement from Nasus Pharma Ltd. ( ($NSRX) ) is now available. On December 22, 2025, Nasus Pharma Ltd. released a shareholder letter from ...

In winter, cold and dry air and indoor and outdoor temperature differences make it easy to catch a cold. At this time, colds ...

Dear Shareholders, 2025 has been a transformational year for Nasus Pharma. We’ve made considerable progress building a strong, focused company with significant clinical impact, by developing drug ...

The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...

The most pronounced increase in pathology tests is seen among children aged 6-11 years, where allergy testing volumes grew ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment of severe asthma characterised by an ...

These days respiratory infections are lasting longer in children If you are wondering what is the reason behind this our expert answers all your queries Read on ...

Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma", "Nasus" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative ...